This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (6)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

SUEL A. SHELDON, M.D.; E. RICHARD HARRELL, M.D.; ARTHUR C. CURTIS, M.D.

AMA Arch Derm. 1956;74(1):9-13.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Vitiligo, an acquired, idiopathic leucoderma, has long been a vexing therapeutic problem for the physician. Therapy for this affliction has included use of ultraviolet light, freezing with carbon dioxide snow, injections of gold thiosulfate, topical applications of bergamot oil, administration of pituitary melanocyte-stimulating hormone (MSH), and the systemic and tropical use of the psoralen compounds. We wish to present our experiences with the last-named substances.

For many centuries, Egyptians have used the fruit of the Ammi majus Linn, plant in the treatment of vitiligo. A powder was prepared from this plant and ingested with simultaneous exposure of the affected skin to sunlight. While this treatment often produced improvement or a cure, its use not infrequently provoked numerous undesirable side-effects, including erythema and vesiculation of the skin, vomiting, diarrhea, nausea, headache, nephritis, hepatitis, coma, and exfoliative dermititis.

In 1947, Fahmy and Abu-Shady isolated from the crude . . . [Full Text PDF of this Article]

Author Affiliations
Ann Arbor, Mich.

From the Department of Dermatology and Syphilology, University Hospital, University of Michigan Medical School.

Footnotes
Submitted for publication June 10, 1955.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?